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Application of Information Theory to Decision Analysis in Potentially
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DAVID A. DANFORD, MD, HOWARD P. GUTGESELL, MD, FACC,
DAN G. McNAMARA, MD, FACC
Houston, Texas
To define settings in which use of prostaglandin E1 before
transfer from a community hospital to a tertiary care
center benefits neonates with possible heart disease, in-
formation theory was used to predict the probability of
a favorable response to prostaglandin therapy from the
limited information of clinical variables. Records of 250
patients, newborn to 7 days old, with suspected heart
disease were reviewed to assess six clinical variables (cy-
anosis, respiratory distress, heart murmur, pulse con-
tour, hepatomegaly and prematurity). According to the
anatomic and hemodynamic cardiovascular condition,
each case was categorized as to whether a favorable
response to prostaglandin E1 could be anticipated. In-
formation content of each clinical variable with respect
to prostaglandin responsiveness was determined, and
patients were classified according to the most informa-
tive clinical variable. Stepwise extraction of information
proceeded until remaining clinical variables added no
Prostaglandin E1 is a very effective method for maintaining
patency of the ductus arteriosus in newborns with ductal-
dependent congenital heart disease (1). However, serious
complications related to prostaglandin E1 administration (2)
preclude its indiscriminate use. The referral of a neonate
with suspected congenital heart disease from a distant hos-
pital to a cardiology center poses an immediate clinical
dilemma that must be approached with limited information.
Should prostaglandin therapy be started before definitive
diagnosis, or should it be withheld for a time to allow for
transfer of the infant and echocardiographic or angiocar-
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significant information. Bayes' rule gave estimates of
probability of prostaglandin-responsive defect in final
subgroups for use in decision analysis.
Cyanosis, murmur, small volume pulses and pre-
maturity gave information about prostaglandin-respon-
sive defects. Decision analysis indicated that frequency
of poor outcome is minimized by early prostaglandin
treatment of cyanotic term infants with a murmur or
poor pulses, regardless of how ill they appear, and by
treating any critically ill term newborn who has either
cyanosis or poor pulses. Acyanotic patients with normal
pulses are best untreated with prostaglandin until after
definitive diagnosis is made. Advantage to either course
was not seen in some small subgroups. Information the-
ory with decision analysis is a rigorous approach to iden-
tify relevant clinical variables and define their roles in
critical decisions in pediatric cardiology.
(J Am Coli CardioI1986;8:1125-30)
diographic diagnosis? A telephone description of the history
and physical examination is usually available to the con-
sultant. On the basis of this limited information, rather than
on an anatomic diagnosis, the consultant must decide about
administering prostaglandin therapy before transfer or en
route.
To assist in making such decisions, the clinical diagnostic
process can be modeled as the stepwise reduction of diag-
nostic uncertainty on the basis of sequential observation and
testing (3,4). Sequential applicaton of Bayes' theorem has
allowed the determination of probability estimates for some
rheumatologic, gastroenterologic and cardiovascular dis-
eases on the basis of laboratory testing (5-7). Information
theory is a relatively new mathematical technique that can
be applied to select those observations and tests with sig-
nificant information content from those that are less inform-
ative, and thus focus clinical attention and resources on
worthwhile testing (8-11).
This investigation applied information theory to the im-
mediate prostaglandin decision by identifying the obser-
vations that supply relevant information. On the basis of
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simple empiric observations about an infant, an estimate of
probability of a prostaglandin-responsive lesion is derived ,
suitable for application in clas sical deci sion analysis .
Methods
Patients. We reviewed the records of 250 patients , 7
days of age or younger, who were referred to our hospital
for known or suspected cardiovascular disease. Six clinical
findings were assessed at the time of referral , and described
as either positi ve or negative (cyanosis , respiratory distress ,
heart murmur, poor pulses , hepatomegaly and prematurity).
The patients were classified on the basis of their cardio-
vascular lesion as either potentially prostaglandin Ej-re-
sponsive or not potentially responsive . Lesions designated
potentially responsive were : interrupted aorti c arch , coarc-
tation of the aorta, hypoplastic left heart , critical aorti c
stenosis, critical pulmonary stenosis, pulmonary valve atre-
sia-intact ventri cular septum , transposition of the great ar-
teries and tetralogy of Fallot or tricu spid atresia in those
patients who required a systemic to pulmonary artery shunt
procedure later in the first week of life . The first four anom-
alies listed would theoretically be benefited by an open
ductus arteriosus, which would allow systemic perfusion.
The other five anomalies are palliated by a left to right shunt
through the ductus arteriosus .
Decision analysis. Using methods previously estab-
lished (12- 14), a contingency tree was generated for the
decision whether or not to give prostaglandin E, before
precise diagnosis (Fig. 1). An adverse outcome of this de-
cision is defined as a serious complication resulting from a
wrong decision; if prostaglandin E, is given, this is the rate
of life-threatening complications or serious permanent se-
quelae from prostaglandin E) administration (Fig . I, route
I). If prostaglandin E) is withheld , this is the frequency of
prostaglandin-responsive lesions times the frequency of life-
threatening events or events with serious permanent seque-
lae while awaiting transfer and diagnosis (Fig. I, route II).
To justify the early administration of prostaglandin £"
the probability of an adverse outcome if prostaglandin is
given must be less than the probability of an adverse out-
come if it is withheld. Using the contingency tree in Figure
I , prostaglandin E 1 should be given early if:
p(compl PGE) < p(PGER) . p(compl no PGE), (I )
where p(compl PGE) = probability of serious complication
from prostaglandin E" p(PGER) = probability of prosta-
glandin Ej-responsive lesion and p(compl no PGE) = prob-
ability of serious complication from withholding prosta-
glandin E, .
The probability of serious complication from prosta-
glandin £1 was estimated from a large cooperative study
(2) which reported that the incidence of all prostaglandin
Ei-related intercurrent medical events is 21%. Not all events
were potentially life-threatening, and not all events could
be expected to occur in the first 6 hours, so we estimate the
probabil ity of a prostaglandin-related event causing an ad-
verse outcome at 10%.
It is more difficult to estimate the probability of serious
complicationfrom withholding prostaglandin £/. In patients
in extremis (with shock, acidemia or severe respiratory dis-
tress) , we estimate that the probability of an adverse out -
come from withholding prostaglandin E1 from a potentially
responsive patient for 6 hours to allow for transfer and
diagnosis could be as high as 70 to 100%. For other po-
tentially responsive patients who are not critically ill at the
time of referral, the probability of a serious complication
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Figure 1. Contingency tree for the decision to admin-
ister prostagland in E, (PGE) before anatomic diagno-
sis . The probability of arriving at an individual end
result is the product of the probabilities encountered
between the prostaglandin decision and the end result .
Adverse outcomes are reached by following either route
1 or route n. The probabil ity of adverse result I is,
therefore, p (compl PGE) and the probability of adverse
result Il is p(PGER)'p(compl no PGE). To show an
advantage for prostaglandin E, treatment, the proba-
bility of adverse results from giving prostaglandin E1
(route I) must be less than the probabilit y of adverse
results from withholding it (route II). The criterion for
early prostagland in E, treatment is, therefore , when
p(compl PGE) < p(pGER)·p (compl no PGE). Compl
no PGE = compl ication from withholding of prosta-
glandin E1; Compl PGE = compli cation from admin-
istration of prostaglandin E1; NPGER = no potentially
prostagland in-responsive card iac lesion ; p = proba-
bility; PGER = potentially prostaglandin-responsive
cardiac lesion .
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s = - L p(D + IT j)log2 p(D + ITj ) , (3)
i = I
where p(D +IT;) is the probability of disease given test result
i. When there are only two possible test results (positive or
negative), equation 3 simplifies :
S = -p(D +IT+) log, p(D+IT+)
- p(D+rr- )log 2 p(D+IT-). (4)
Information content (IC) of a test then is simply the reduc-
tion of uncertainty achieved by the test:
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pretest entropy of zero cannot be further reduced by the
test. The significance of information content can be tested
using a chi-square distribution after the method of Ulm et
al. (8).
Algorithm. The six clinical observations were subjected
to analysis of information content for the question of pros-
taglandin E. response potential using equations 4 and 5.
The observation or test with the highest information content
was selected to divide the group into higher and lower like-
lihood subgroups. The remaining five observations were
subjected to analysis of information content within the
subgroups , and the factor with the greatest value was se-
lected to divide the subgroups. This procedure was contin-
ued sequentially until no remaining factor provided signif-
icant information within any of the subgroups (p < 0.05
by chi-square analysis for large samples or Fisher exact test
for small samples) (8).
Probability estimates. Estimates of probability of a po-
tentially prostaglandin Ej-responsive lesion by direct cal-
culation of the incidenceofresponsive lesions in each subgroup
may be misleading because of the small numbers in some
of the subgroups. The probability of a responsive lesion was
therefore estimated by sequential application of Bayes' theo-
rem where applicable (15) ;
p(D + IT +) = p(D + )p(T :~~:)t~;:~~ ;P(T +!D _ ) (6)
0.1 0.5 1.0
p (campi no PGE)
Figure 2. The threshold p(PGER) for early prostaglandin E 1 (POE)
treatment shown on the vertical axis is that probability of a re-
sponsive lesion above which a clinician theoretically would min-
imize adverse outcome by treating with prostaglandin E 1 before
definitive diagnosis. The threshold is a function of the probability
of a complication from withholding of prostaglandin E, [p(compl
no POE)]. which in turn depends on how ill the patient is. This
curve is a sensitivity analysis of the influence of varying p(compl
no PGE) on the threshold for early prostaglandin E. treatment. At
high values of p(compl no PGE), relatively large changes in p(compl
no PGE) result in relatively small changes in threshold for treat -
ment. Abbreviations as in Figure I.
(5)Ie = Sprot e" - Spost-Iest.
Entropy and information content are expressed in terms
of bits. When total uncertainty exists, entropy is at its max-
imal value of one bit. When perfect certainty exists, entropy
is zero. Information content of a perfect test in the setting
of total pretest uncertainty is maximal (one bit) . Test im-
perfections (false positives and false negatives) decrease the
information content. The information content of a test is
also limited by pretest entropy. For example, when perfect
certainty exists before the application of a test, the infor-
mation content of even a perfect test is zero because the
from withholding prostaglandin E1 is probably much lower ,
perhaps 25 to 33%.
Using these figures, the inequality (1) can be solved for
the probability of a prostaglandin-responsive cardiac lesion.
Figure 2 shows the relation between the threshold proba-
bility of a prostaglandin-responsive cardiac lesion, which
one would wish to treat before transfer is completed, and
the probability of a serious complication from withholding
prostaglandin E1• In very ill patients with a high probability
of a serious complication from withholding prostaglandin
E., relatively large changes in probability of a serious com-
plication from withholding prostaglandin E. result in small
changes in the threshold for treatment. For patients in ex-
tremis with a 70 to 100% probability of a serious compli-
cation from withholding prostaglandin E1, the threshold
probability of a prostaglandin-responsive cardiac lesion for
treatment is 10 to 14%. For patients who are not so acutely
ill in whom the estimated probability of a serious compli-
cation from withholding prostaglandin E1 is 25 to 33% , the
threshold probability of a prostaglandin-responsive cardiac
lesion for treatment is 30 to 40% .
Information theory. As reviewed recently by Diamond
and Forrester (3), information theory defines a quantity of
uncertainty or entropy, which can be derived from the prob-
ability of a disease state. Entropy (S) can be defined math-
ematically as:
S = - p(D + jlog, p(D +) - p(D - )log2 p(D - ), (2)
where p(D +) is the probability of disease, and p(D -) is
the probability of no disease. After a test or observation (T)
with n possible outcomes:
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Results
*Relative to the potential response to prostaglandin
E, (by modified chi-square analysis).
Table 1. Information Content of Each Variable
in the EntireGroupof 250 Patients
The information content of all six clinical variables for
the group as a whole is shown in Table 1. Cyanosis was
by far the most informative variable and was, therefore,
used to divide the group into subgroups with a high prob-
ability of a prostaglandin Ej-responsive lesion (cyanotic)
and a low probability of a responsive lesion (acyanotic). In
the cyanotic subgroup (Table 2), a heart murmur was the
most informative variable, whereas weak pulses were most
informative in the acyanotic subgroup. These variables were
used to subdivide the subgroups. This process was continued
until no observation or laboratory test provided further sig-
nificant (p < 0.05) information. In this way, the information
tree in Figure 3 was generated.
Some findings carried significant information within the
group as a whole, but became insignificant after subdivisions
were made. This illustrates that information carried by dif-
ferent variables may overlap or that one finding may be
dependent on another. Observations that carried significant
information content were cyanosis, heart murmur, weak
pulses and premature gestational age. Eight final subgroups
were generated, each with its own estimated probability of
a potentially responsive lesion (Fig. 4).
Patients in extremis. Among very ill newborns, if pros-
taglandin E1 is withheld from those with potentially re-
sponsive heart disease, the probability of an adverse course
approaches 1.0. The threshold probability of a prostaglan-
din-responsive lesion necessary to sway the clinician to ad-
minister prostaglandin E) to infants in such dire straits is
relatively low (approximately 0.10) (Fig. 2). The estimated
probability of a responsive lesion is much higher than the
threshold for treatment before diagnosis in all term cyanotic
patients and in all term patients with weak pulses if they
are in extremis. It is also clear that probability values in
acyanotic patients with good pulses fall below the threshold
for treatment before diagnosis. Acyanotic premature infants
with weak pulses and cyanotic premature infants with weak
pulses but no murmur are ambiguous groups lacking stan-
dard statistical certainty (95% confidence) that probability
values are above or below threshold. However, the bulk of
the probability distribution is above threshold for early treat-
ment in both of these groups.
Patients not in extremis. Among patients not in ex-
tremis at the time of referral, who might be expected to
have 0.25 to 0.33 probability of a complication if prosta-
glandin is withheld, values in cyanotic infants with murmurs
or cyanotic term infants with weak pulses are above the
threshold for treatment. Values in acyanotic infants with
good pulses are far below the threshold for treatment. The
Information Content
(bits)
0.138 }0.065
0.023 P < 0.05*
0.021
0.020
0.002
Cyanosis
Weak pulses
Prematurity
Heart murmur
Hepatomegaly
Respiratory distress
Finding
The values for probability of disease [p(T + ID +) and
p(T + ID -)] were taken from the entire group of 250 pa-
tients only if the observed incidence of p(D + IT +) satis-
factorily matched the estimate from Bayes' theorem (p <
0.05 on goodness of fit testing by chi-square or Fisher exact
test) (16). Because Bayes' theorem is appropriate only when
tests are independent of one another (17), the goodness of
fit test in effect measures the independence of the sequential
tests. If independence could not be established among all
the sequential tests, then p(T + ID +) and p(T +ID - ) were
taken from the largest subgroup, after which the final test
was independent of the preceding tests; p(D +) was thus
calculated for all the terminal subgroups. The beta-proba-
bility distribution (18) was used to determine the median
and 95% confidence limits of the probability of a responsive
lesion, after the method of Diamond and Forrester (3).
Table 2. Information Content Regarding Prostaglandin E, Responsiveness for Each Remaining
Variable After the First Division of the Group (cyanotic versus acyanotic)
Cyanotic Acyanotic
Finding
Information Content
(bits) Finding
Information Content
(bits)
Heart murmur
Weak pulses
Prematurity
Respiratory distress
Hepatomegaly
0.063 }
p < 0.05*
0.062
0.016
0.003
0.000
Weak pulses
Hepatomegaly
Gestational age
Respiratory distress
Heart murmur
0.157 }
0.079 P < 0.05*
0.044
0.031
0.004
*Relative to the potential response to prostaglandin E!.
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Figure 3. The information tree produced by
the algorithm . f3 = lower and upper 95%
confidence limits for the beta-probability dis-
tribution for the probability of a potentially
prostaglandin-responsive lesion; M = me-
dian of beta-probability distribution (because
of the asymmetry of the beta-probability dis-
tribution, the median does not equal the mean;
the median has been advocated as the appro-
priate statistic for decision making [3]); N =
number of patients in each subgroup; pts =
patient; + = finding present; - = finding
absent.
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probability distributions for the remaining groups straddle
the threshold for treatment to a greater or lesser extent. The
bulk of the probability distribution is above the threshold
for treatment of term acyanotic infants with weak pulses
and in cyanotic premature infants with weak pulses . Most
of the distribution for infants with cyanosis only and for
acyanotic premature infants with weak pulses is below
threshold for early prostaglandin E1 therapy.
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Figure 4. Medians and 95% upper and
lower confidence limits are shown for the
likelihood of a potentially prostaglandin-
responsive lesion [p(PGER)] for each ter-
minal subgroup. The upper shaded area
represents the threshold probability of a
responsive cardiac lesion for early pros-
taglandin E1 treatment of patients not in
extremis . The lower shaded area is the
threshold for early prostaglandin E1 treat-
ment of patients in extremis. C = cy-
anosis; M = rnurmur; P = poor pulses;
Pre = premature; + = finding present;
- = finding absent.
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Discussion
With the increasing availability of prostaglandin E( at
referring hospitals, an empiric method to determine which
infants would profit from its administration before definitive
diagnosis is important. This type of problem in which crucial
clinical decisions must be made with limited information,
is well suited to analysis based on information theory. Im-
portant clinical variables relevant to the probability of a
prostaglandin Ej-responsive lesion are the presence or ab-
sence of cyanosis, the presence or absence or a heart mur-
mur, the quality of pulses and the gestational age. Whether
or not the patient is in extremis at the time of referral alters
the decision-making process by changing the threshold for
treatment. This analysis substantially reduces the observa-
tions that might be considered or tests that might be ordered
before making a decision that cannot safely be delayed . In
most cases, the probability of prostaglandin E1 responsive-
ness clearly is above or below threshold , allowing a decision
that is well justified.
Advantages and disadvantages of the method. Deci-
sion analysis has rarely been applied in pediatric cardiology
(13 ,14,19,20) and, to our knowledge, formal information
theory has not been applied and published before . This
approach has the advantage of being mathematically rig-
orous. If underlying assumptions are sound, the method
should provide reliable results. The guidelines for early
prostaglandin therapy derived here are clinically reasonable,
a fact that tends to validate the method . Information theory
with decision analysis does not require access to a computer
for the analysis of each case . Instead, easily applicable
guidelines for decision making may be formulated in ad-
vance . The disadvantages of the approach are, first, that it
requires a large data base for meaningful information anal-
ysis. Second, the decision in cases where the probability
distribution straddles the threshold for action is ambiguous .
As long as information is incomplete, categories of patients
will exist in which it will be difficult to prove an advantage
for one course of action over another. Although a clinician
could not be proved wrong for choosing otherwise, it is
probably best to compare the median of the probability
distribution with the threshold for decision making in am-
biguous circumstances. Finally, the generalization of the
results of our study to other practices of pediatric cardiology
is contingent on similarities of patient populations seen,
transfer times and the like . Similarly, as diagnostic and
treatment options improve over the years, studies such as
this will require review to determine if the assumptions on
which they are based are still true .
Applications. Many potential applications of this method
exist in pediatric cardiology , a field in which the information
available is often incomplete and dispersed throughout many
observations and laboratory results. Improvements in clin-
ical practice through the elimination of noncontributory test-
ing and the minimization of adverse outcome are the po-
tential rewards of a more general application of this type of
analysis .
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